Ms. Richo brings more than 30 years of global
legal, compliance, and regulatory experience to
Illumina's Board
SAN
DIEGO, May 20, 2024 /PRNewswire/ -- Illumina,
Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of
Directors following shareholder approval of the director slate at
the company's May 16, 2024, annual
meeting. Ms. Richo currently serves as Corporate Senior Vice
President, Strategic Advisor to the General Counsel and CEO at
Cargill, Inc. a global food production and agricultural
company.
Ms. Richo brings more than 30 years of regulated-industry
experience as an attorney and legal executive, with extensive
experience in compliance and business ethics, intellectual
property, and corporate litigation. She formerly served as
Corporate Senior Vice President, General Counsel, Chief Compliance
Officer, and Corporate Secretary at Cargill, where she oversaw the
company's corporate governance, global ethics and compliance,
global security, global government relations, law, and shareholder
relations functions.
Prior to joining Cargill, Ms. Richo was Executive Vice President
and General Counsel at UCB, a biopharmaceutical company based in
Belgium. She also served as Senior
Vice President and Chief Compliance Officer at Amgen, a global
biotechnology company, and as Chief Litigation Counsel, Associate
General Counsel, and Vice President of Law at Baxter
Healthcare.
"I am thrilled to welcome Anna to our Board of Directors," said
Jacob Thaysen, CEO of Illumina. "In
today's evolving business and regulatory environment, her extensive
global legal, compliance, and regulatory experience, including at
biotechnology, biopharmaceutical, and medtech companies, will
enhance our evaluation and understanding of the risks and
opportunities associated with Illumina's expanding worldwide
operations."
Ms. Richo also serves as a member of Exelon's Board of
Directors, as a member of the Cargill Foundation Board of
Directors, on the Board of Trustees for DePaul
University, and on the Children's Minnesota Governance
Board.
Ms. Richo holds a B.S. in Industrial and Labor Relations from
Cornell University and a J.D. from
DePaul University College of Law.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as a global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical, and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture, and other emerging segments. To
learn more, visit www.illumina.com and connect with us
on X(Twitter), Facebook, LinkedIn, Instagram, TikTok,
and YouTube.
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
Bonny Fowler
740-641-5579
PR@illumina.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/anna-richo-joins-illuminas-board-of-directors-302150329.html
SOURCE Illumina, Inc.